Amir Bayat, Alireza Sharafshah, Farshid Sefat, Milad Rahimzadegan, Mohammad Raad, Kai-Uwe Lewandrowski
{"title":"New Insights into Colorectal Cancer through the Lens of Precision Oncology and Personalized Medicine: Multi-Omics Helps Aging of Predisposed People.","authors":"Amir Bayat, Alireza Sharafshah, Farshid Sefat, Milad Rahimzadegan, Mohammad Raad, Kai-Uwe Lewandrowski","doi":"10.2174/0118746098348122241024061610","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recently, there has been a significant evolution in our understanding of the molecular pathways causing the genesis and progression of cancer via the inter-individual variations. Thus, one-size-fits-all methods for cancer treatment have been replaced by precision oncology (PO) targeting individual cancer symptoms, offering increased effectiveness, and decreased safety concerns and cost load.</p><p><strong>Objective: </strong>The identification of novel actionable indications, rapid, precise, and comprehensive detection of complex phenotypes in every individual, pioneering clinical trial projects with enhanced response feedback, and widespread availability of innovative targeted anticancer management for every patient are vital for the effective implementation of next-generation precision oncology. Additionally, the emergence of precision medicine has altered the perspective of oncologic biomarkers, drug discovery, drug development, and, improvements for cancer patients.</p><p><strong>Method: </strong>This paper narratively reviewed to identify actionable abnormalities, Genomic profiling of tumors employing clinical next-generation sequencing (NGS) from both tumor tissues and liquid biopsies along with the multi-omics strategies as the key component of PO.</p><p><strong>Results: </strong>Our increasing information on tumor biology, specifically microenvironment and heterogeneity- associated data, would improve our understanding of the resistance of targeted drugs and specific mechanisms of action, as well as help enhance existing metastatic colorectal cancer (mCRC) treatment strategies.</p><p><strong>Conclusion: </strong>Collectively, this paper indicated the current and innovative strategies for prognosis, diagnosis, and treatment of various cancer types based on PO overview with a groundbreaking emphasis on CRC suggesting the integrations of multi-omics, highlighting Genomics, and utilizing AL and ML algorithms with targeted therapies. Notably, these findings can help improve the life-span and ageing of the predisposed people.</p>","PeriodicalId":11008,"journal":{"name":"Current aging science","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current aging science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118746098348122241024061610","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Recently, there has been a significant evolution in our understanding of the molecular pathways causing the genesis and progression of cancer via the inter-individual variations. Thus, one-size-fits-all methods for cancer treatment have been replaced by precision oncology (PO) targeting individual cancer symptoms, offering increased effectiveness, and decreased safety concerns and cost load.
Objective: The identification of novel actionable indications, rapid, precise, and comprehensive detection of complex phenotypes in every individual, pioneering clinical trial projects with enhanced response feedback, and widespread availability of innovative targeted anticancer management for every patient are vital for the effective implementation of next-generation precision oncology. Additionally, the emergence of precision medicine has altered the perspective of oncologic biomarkers, drug discovery, drug development, and, improvements for cancer patients.
Method: This paper narratively reviewed to identify actionable abnormalities, Genomic profiling of tumors employing clinical next-generation sequencing (NGS) from both tumor tissues and liquid biopsies along with the multi-omics strategies as the key component of PO.
Results: Our increasing information on tumor biology, specifically microenvironment and heterogeneity- associated data, would improve our understanding of the resistance of targeted drugs and specific mechanisms of action, as well as help enhance existing metastatic colorectal cancer (mCRC) treatment strategies.
Conclusion: Collectively, this paper indicated the current and innovative strategies for prognosis, diagnosis, and treatment of various cancer types based on PO overview with a groundbreaking emphasis on CRC suggesting the integrations of multi-omics, highlighting Genomics, and utilizing AL and ML algorithms with targeted therapies. Notably, these findings can help improve the life-span and ageing of the predisposed people.
背景:最近,我们对通过个体间差异导致癌症发生和发展的分子途径的认识有了重大发展。因此,针对个体癌症症状的精准肿瘤学(PO)取代了 "一刀切 "的癌症治疗方法,提高了疗效,减少了安全隐患和成本负担:确定新的可采取行动的适应症,快速、精确、全面地检测每个个体的复杂表型,开展具有增强反应反馈的开创性临床试验项目,以及为每位患者广泛提供创新的靶向抗癌治疗,这些对于有效实施下一代精准肿瘤学至关重要。此外,精准医学的出现也改变了人们对肿瘤生物标志物、药物发现、药物开发以及改善癌症患者的看法:本文综述了肿瘤组织和液体活检的临床新一代测序(NGS)以及作为 PO 关键组成部分的多组学策略,以确定可操作的异常、肿瘤基因组图谱:结果:我们对肿瘤生物学,特别是微环境和异质性相关数据的了解不断增加,这将提高我们对靶向药物耐药性和特定作用机制的认识,并有助于加强现有的转移性结直肠癌(mCRC)治疗策略:总之,本文基于 PO 概述,指出了当前和创新的各种癌症类型的预后、诊断和治疗策略,并突破性地强调了 CRC,建议将多组学、突出基因组学以及利用 AL 和 ML 算法与靶向治疗相结合。值得注意的是,这些发现有助于改善易感人群的寿命和衰老状况。